Loading...
Loading...
US generic drug make Mylan
MYL is mulling a bid for Sweden's Meda, according to
Financial Times. Sources report Mylan has hired adivsors to help put together a deal, which would create a $23 billion pharmaceutical company.
View full article http://www.ft.com/intl/cms/s/0/24aababc-bb78-11e3-8d4a-00144feabdc0.html#axzz2xuU35ONe
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in